December 29, 2016 by Chain Drug Review
Daryl Katz, Domenic Pilla, John Hammergren, Jürgen Schreiber, Katz Group, McKesson, McKesson Canada, Paul Julian, Paula Keays, Rexall Health
Business, Featured Articles, Leading Headlines, Retail News
SAN FRANCISCO and TORONTO — McKesson Corp. has closed its $2.1 billion (U.S.) acquisition of Canadian drug chain Rexall Health and hired Domenic Pilla as chief executive officer of McKesson Canada. McKesson said late Wednesday that Pilla is slated to take the reins as McKesson Canada CEO on Jan. 3. In the role, he will
March 14, 2016 by Geoff Walden and Chain Drug Review
Alain Champagne, Daryl Katz, John Hammergren, Jürgen Schreiber, Katz Group, McKesson, McKesson Canada, Paul Julian, Rexall Health
2016, Issue 03-14-2016, Issues, News
TORONTO — McKesson Corp.’s $2.2 billion deal to acquire Rexall Health from Katz Group will strengthen the drug distributor’s position in Canada’s pharmaceutical supply chain. McKesson said the agreement is a natural next step for two companies that have worked together for over 20 years. In 2012, McKesson bought Katz’s 1,100-store banner operation covering I.D.A.,
March 14, 2016 by Jeffrey Woldt and Chain Drug Review
Canadian pharmacy market, Jean Coutu Group, Jeffrey Woldt, Katz Group, Lawtons Drugs, Loblaw, McKesson, Rexall Health, Shoppers Drug Mart, Sobeys
2016, Issue 03-14-2016, Issues, Leading Headlines, Opinion
McKesson Corp.’s agreement to acquire Rexall Health from Katz Group is notable in several respects. The transaction alters the balance of power in the Canadian pharmacy market. In addition, it offers confirmation, if any were needed, of the relentless drive among major players in the sector to increase their scale and, in the process,
March 2, 2016 by John Schultz and Chain Drug Review
Daryl Katz, John Hammergren, Jürgen Schreiber, Katz Group, McKesson, McKesson Canada, Paul Julian, Rexall Health
Business, Featured Articles, Leading Headlines, Retail News
SAN FRANCISCO and TORONTO — McKesson Corp. plans to acquire Canadian drug store operator Rexall Health from Katz Group for $2.2 billion ($3 billion Canadian). McKesson said Wednesday that the deal will strengthen its position in Canada’s pharmaceutical supply chain and is a natural step for the two companies, which have worked together for more
June 15, 2015 by Chain Drug Review
Daryl Katz, Jürgen Schreiber, Katz Group, Rexall Health, Shoppers Drug Mart
2015, Issue 06-15-2015, News
EDMONTON, Alberta — Canada’s Rexall/Rexall Pharma Plus drug chain has a new chief executive officer and a new operating structure. Former Shoppers Drug Mart chief executive Jürgen Schreiber has been named CEO of Rexall Health, a newly formed banner under the Katz Group. Plans call for Schreiber, who joins the company from Edcon Group, South
June 15, 2015 by Geoff Walden and Chain Drug Review
99 Cents Only Stores, Andy Giancamilli, Katz Group
2015, Issue 06-15-2015, News
CITY OF COMMERCE, Calif. — Former Katz Group head Andy Giancamilli has been named interim president and chief executive officer of 99 Cents Only Stores. Giancamilli, who was appointed chairman of the chain in April, replaced Stéphane Gonthier, who resigned. “In my role on the board over the past three years, and more recently as
May 28, 2015 by John Schultz and Chain Drug Review
Claimsecure, Daryl Katz, Edcon Group, Jürgen Schreiber, Katz Group, Medicentres Canada, Rexall, Rexall Health, Rexall Pharma Plus
Business, Featured Articles, Leading Headlines, Retail News
EDMONTON, Alberta – Former Shoppers Drug Mart chief executive officer Jürgen Schreiber has been named CEO of Rexall Health, a newly formed banner under the Katz Group. Rexall said Thursday that Schreiber, who joins the company from Edcon Group, South Africa’s largest nonfood retailer, is slated to take the helm as CEO in August. In